Error: Could not add to watchlist. X
+ Watchlist

Acerus Pharmaceuticals Corp

ASP:CN
Toronto
0.11
CAD
0.01
10.53%
As of 3:26 PM EDT 7/29/2016
Open
0.10
Day Range
0.10 - 0.11
Volume
22,315
Previous Close
0.10
52Wk Range
0.08 - 0.50
1 Yr Return
-78.12%
Open
0.10
Day Range
0.10 - 0.11
Volume
22,315
Previous Close
0.10
52Wk Range
0.08 - 0.50
1 Yr Return
-78.12%
YTD Return
-12.50%
Current P/E Ratio (TTM)
2.28
Earnings per Share (USD) (TTM)
0.04
Market Cap (m CAD)
22.377
Shares Outstanding (m)
213.119
Price/Sales (TTM)
0.67
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Trimel Pharmaceuticals Corp. is a pharmaceutical development company. The Company's primary objective is to exploit Trimel's drug-delivery technology portfolio and to target unmet medical needs in underserved disease states. Trimel's term objectives include the development of products for the treatment of male hypogonadism, female sexual dysfunction, and Parkinson's disease.
Address
2486 Dunwin Drive
Mississauga, ON L5L 1J9
Canada
Phone
1-416-679-0771
Show More